Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PFE

Pfizer Inc

Nov 10 • 04:00PM ET

24.39

-0.04 -0.16 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Scroll to Statements

Index	S&P 500	P/E	14.22	EPS (ttm)	1.72	Insider Own	0.12%	Shs Outstand	5.69B	Perf Week	-1.09%
Market Cap	138.67B	Forward P/E	7.77	EPS next Y	3.14	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	-1.57%
Enterprise Value	185.70B	PEG	-	EPS next Q	0.65	Inst Own	66.77%	Short Float	2.06%	Perf Quarter	-1.05%
Income	9.80B	P/S	2.21	EPS this Y	0.84%	Inst Trans	-1.16%	Short Ratio	1.97	Perf Half Y	5.63%
Sales	62.78B	P/B	1.49	EPS next Y	0.04%	ROA	4.58%	Short Interest	116.82M	Perf YTD	-8.07%
Book/sh	16.32	P/C	9.25	EPS next 5Y	-0.62%	ROE	10.59%	52W High	27.69 -11.92%	Perf Year	-10.86%
Cash/sh	2.64	P/FCF	13.36	EPS past 3/5Y	-28.69% -13.27%	ROIC	6.52%	52W Low	20.92 16.61%	Perf 3Y	-47.63%
Dividend Est.	1.70 (6.96%)	EV/EBITDA	7.03	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	69.53%	Volatility	2.97% 1.79%	Perf 5Y	-28.89%
Dividend TTM	1.72 (7.05%)	EV/Sales	2.96	EPS Y/Y TTM	128.96%	Oper. Margin	31.40%	ATR (14)	0.55	Perf 10Y	-26.59%
Dividend Ex-Date	Nov 07, 2025	Quick Ratio	0.97	Sales Y/Y TTM	4.44%	Profit Margin	15.60%	RSI (14)	45.38	Recom	2.46
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.28	EPS Q/Q	-20.96%	SMA20	-0.67%	Beta	0.42	Target Price	28.61
Payout	120.11%	Debt/Eq	0.66	Sales Q/Q	-5.92%	SMA50	-1.39%	Rel Volume	2.58	Prev Close	24.43
Employees	81000	LT Debt/Eq	0.62	Earnings	Nov 04 BMO	SMA200	-0.92%	Avg Volume	59.35M	Price	24.39
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	37.53% 0.94%	Trades		Volume	148,958,624	Change	-0.16%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 05:30AM	Obesity Drugs Are About to Go Mass-Market (The Wall Street Journal)
04:25AM	Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? (Motley Fool)
04:10AM	Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring (Motley Fool)
01:02AM	Novo Nordisk Shares Pop After Stepping Back From Metsera Chase (GuruFocus.com)
12:36AM	The Top 5 Analyst Questions From Pfizer's Q3 Earnings Call (StockStory)
09:55AM	Loading…
Nov-10-25 09:55AM	Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion (Investor's Business Daily)
04:59PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:45PM	Stocks to Watch Monday: Paramount, Barrick Mining, Pfizer, Tyson Foods (The Wall Street Journal)
04:15PM	These Stocks Moved the Most Today: Metsera, Nvidia, Tesla, Rumble, MP Materials, Viasat, Monday.com, CoreWeave, and More (Barrons.com)
01:09PM	Pfizer Wins Obesity Drug Battle, With Assist by Trumps FTC (Bloomberg)
12:57PM	Pfizer Clinches $10 Billion Deal for Metsera After Fierce Bidding War With Novo Nordisk (GuruFocus.com)
12:46PM	These Stocks Are Moving the Most Today: Metsera, Nvidia, Tesla, Rumble, MP Materials, Viasat, Monday.com, CoreWeave, and More (Barrons.com)
10:49AM	Metsera (MTSR) Shares Nosedive After Pfizer Clinches Weight-Loss Biotech Deal (GuruFocus.com)
10:45AM	Novo Nordisk Walks Away from $10 Billion Fight--And the Stock Rallies Anyway (GuruFocus.com)
10:36AM	What's Next for Novo Nordisk? (The Wall Street Journal)
10:30AM	Loading…
10:30AM	Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs (CNBC TV)
10:00AM	Pfizer Wins Battle for Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Real Winner. (Barrons.com)
09:57AM	Novo Nordisk shares rise on investor relief after it exits Metsera bid (Reuters Videos)
09:42AM	Pfizer Wins Obesity War Against NVO, to Buy Metsera for Around $10B (Zacks)
09:33AM	Pfizer & Metsera, Monday.com, Instacart: Trending Tickers (Yahoo Finance Video)
09:11AM	Here Are Mondays Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More (24/7 Wall St.)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:54AM	Bristol Myers Gains 7.2% in a Month: Buy, Sell or Hold the Stock? (Zacks)
08:11AM	5 Things to Know Before the Stock Market Opens (Investopedia)
08:08AM	Pfizer clinches $10bn Metsera deal as Novo Nordisk retreats (Pharmaceutical Technology)
08:05AM	Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call. (MarketWatch)
07:47AM	Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? (Zacks)
07:32AM	Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Real Winner. (Barrons.com)
05:34AM	These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, CoreWeave, and More (Barrons.com)
04:38AM	Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle (The Wall Street Journal)
04:18AM	Loading…
04:18AM	Novo Rises After Bowing Out of Metsera Takeover Battle (Bloomberg)
04:17AM	Norway wealth fund abstains from Novo board vote; Stock up on dropped Metsera bid (Investing.com)
Nov-09-25 08:30AM	Inside Yahoo Finance Invest 2025: The top question that must be answered (Yahoo Finance)
07:30AM	Valuation worries, record-long government shutdown hang over markets: What to watch this week (Yahoo Finance)
Nov-08-25 12:34PM	Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk (Associated Press Finance)
09:15AM	2 No-Brainer Dividend Stocks to Buy With $100 in November (Motley Fool)
08:52AM	This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. (The Wall Street Journal)
08:17AM	Pfizer wins $10 billion Metsera bidding war as Novo Nordisk exits (Reuters Videos)
08:10AM	Pfizer and Metsera Reach Deal Expected to Top $10 Billion (The Wall Street Journal)
06:56AM	Pfizer wins bidding war for Metsera with $10B offer (BioPharma Dive)
04:17AM	Pfizer wins $10bn bidding war for weight-loss start-up Metsera (Financial Times)
Nov-07-25 10:07PM	Pfizer and Metsera Reach Deal Worth Up to $10 Billion (The Wall Street Journal)
02:10PM	Why Novo Nordisk Stock Is Sinking This Week (Motley Fool)
01:02PM	Chinas Stocks are Flying as Beijing Doubles Down on Tech. Why the Economy Is Still Struggling. (Barrons.com)
11:46AM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
11:28AM	Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call (Zacks)
11:22AM	The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. (Investor's Business Daily)
11:11AM	"Pfizer (PFE) Beat The Numbers And People Just Yawned," Says Jim Cramer (Insider Monkey)
10:44AM	LLY's GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs (Zacks)
08:20AM	Elon Musk pay deal, AI bubble worries and pharma wars (Yahoo Finance Video)
08:20AM	ETF inflows surge as health care names lead gains amid easing headwinds (CNBC TV)
08:16AM	Earnings live: Block stock drops after earnings miss, Airbnb pops, Opendoor pitches turnaround plan (Yahoo Finance)
08:13AM	Pfizer and Novo Nordisk Face Off in $10 Billion Battle for Metsera (GuruFocus.com)
05:30AM	This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. (The Wall Street Journal)
Nov-06-25 10:21PM	Jim Cramer Says Pfizer "Will Continue to Sell at Eight Times Earnings" (Insider Monkey)
05:30PM	Trump inks Eli Lilly & Novo deals: How to play pharma stocks (Yahoo Finance Video)
04:40PM	Earnings live: Airbnb stock jumps, Opendoor pitches turnaround plan, Duolingo stock nosedives (Yahoo Finance)
04:14PM	'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera (Investor's Business Daily)
03:33PM	Analyst Report: Viatris Inc. (Morningstar Research)
03:23PM	Novo Nordisk challenges Pfizer to raise offer for obesity biotech (Financial Times)
03:03PM	Stocks to Watch Thursday: Marvell, Arm, Snap, DraftKings (The Wall Street Journal)
03:02PM	Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. (Barrons.com)
02:20PM	Jim Cramer Highlights the Woes of Pfizer and the Drug Sector (Insider Monkey)
01:34PM	Novo Nordisk and Eli Lilly Can Sell Their Weight-Loss Drugs to Medicare Market (Barrons.com)
12:36PM	No Brainer Dividend Stocks To Buy Now (24/7 Wall St.)
12:05PM	Lilly, Novo to Lower Obesity Drug Prices in Deal With Trump (Bloomberg)
11:58AM	Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans (Zacks)
11:45AM	AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform (Zacks)
11:16AM	Modernas Quarter Wasnt As Bad as It Could Have Been. The Stock Is Up. (Barrons.com)
10:46AM	ESPN & Penn end pact, Metsera bidding war, Boeing case dismissed (Yahoo Finance Video)
08:09AM	Earnings live: Moderna stock pops amid cost-cutting efforts, Snap stock soars, Duolingo plunges (Yahoo Finance)
07:51AM	AstraZeneca CEO bullish on record revenue numbers and US growth (Yahoo Finance Video)
07:29AM	Moderna Swings to a Loss. The Stock Jumps Anyway. (Barrons.com)
04:44AM	Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting (Motley Fool)
04:10AM	2 Dirt Cheap Stocks to Buy With $1,000 Right Now (Motley Fool)
Nov-05-25 06:13PM	Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman (CNBC TV)
05:08PM	Pfizer Responds to Delaware Chancery Court Ruling (Business Wire)
04:52PM	Pfizer Preps Improved Offer in Metsera Bidding War (The Wall Street Journal)
04:33PM	Earnings live: Snap stock soars, DoorDash tumbles, Qualcomm falls after one-time charge (Yahoo Finance)
04:33PM	Earnings live: Snap stock soars, DoorDash and Duolingo plunge in post-earnings swoon (Yahoo Finance)
04:31PM	Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled (Investor's Business Daily)
04:15PM	Moderna Is Running Low on Cash. Its Earnings Are Thursday. (Barrons.com)
03:54PM	FTC signals scrutiny of Novos bid for Metsera (BioPharma Dive)
02:02PM	Arvinas Inc (ARVN) Q3 2025 Earnings Call Highlights: Clinical Advancements and Strategic ... (GuruFocus.com)
11:41AM	Analyst Report: BioNTech SE (Morningstar Research)
10:43AM	Ozempic Maker Novo Nordisk Lowers Growth Outlook (The Wall Street Journal)
10:43AM	Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. (Barrons.com)
08:19AM	Earnings live: AMD, Supermicro, and Novo Nordisk stocks fall, Pinterest tanks while Lemonade gets a boost (Yahoo Finance)
06:52AM	Novo Nordisk and Pfizers bidding war for Metsera escalates despite legal threats (Pharmaceutical Technology)
06:48AM	The AI Stocks Selloff Could be a Bust or a Blip. This Will Decide Which. (Barrons.com)
06:47AM	Novo Nordisk Cuts Growth Outlook as Weight-Loss Drug Pressures Rise (GuruFocus.com)
05:00AM	Novo Nordisk Stock Up After Earnings. Guidance Cut on These Weight-Loss Drug Fears. (Barrons.com)
03:06AM	3 Magnificent Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 8.5% -- to Buy With Confidence in November (Motley Fool)
02:22AM	Google Clears DOJ Antitrust Hurdle for $32 Billion Wiz Deal (Bloomberg)
12:32AM	PFE Q3 Deep Dive: Pipeline, Cost Controls, and Business Development Shape Outlook (StockStory)
12:00AM	AP Top Financial News at 5:43 a.m. EST (Associated Press Finance)
12:00AM	AP Top Extended Financial Headlines at 5:43 a.m. EST (Associated Press Finance)
Nov-04-25 11:31PM	Michael Burry Is Super-Bearish On Palantir With 5 Million Puts (Benzinga)
06:52PM	Obesity Category Still Hot: Mizuho's Jared Holz (Bloomberg)
06:45PM	Stocks to Watch Tuesday: Palantir, Sarepta, Tesla (The Wall Street Journal)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience